Effect of Policosanol as Monotherapy and Adjunctive to Statin Therapy - Trial NCT00510809
Access comprehensive clinical trial information for NCT00510809 through Pure Global AI's free database. This phase not specified trial is sponsored by James Backes, PharmD and is currently Completed. The study focuses on High Cholesterol. Target enrollment is 54 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
Effect of Policosanol as Monotherapy and Adjunctive to Statin Therapy
Safety and Efficacy of Policosanol Monotherapy and When Added to Chronic Statin Therapy: A Pilot Study
Study Focus
Sponsor & Location
James Backes, PharmD
University of Kansas Medical Center
Kansas City, United States of America
Timeline & Enrollment
N/A
Jul 01, 2007
May 01, 2010
54 participants
Primary Outcome
Lipid Profile
Summary
To determine the effects of policosanol on the cholesterol profile.
ICD-10 Classifications
Cholesterolosis of gallbladder
Pure hypercholesterolaemia
Other disorders of lipoprotein metabolism
Disorder of lipoprotein metabolism, unspecified
Disorders of lipoprotein metabolism and other lipidaemias
Data Source
ClinicalTrials.gov
NCT00510809
Non-Device Trial